Professional Documents
Culture Documents
ABSTRACT
A srie of chalcone was synthesed by catalysed claisen schmit condensation and evalated for biological activity
against a various micro-organisme such Staphylococcus aures ATCC, Klebsiela pneumonia ATCC, Escherichia Coli
ATCC, Pseudomonas aeruginosa ATCC using the disk diffusion method and the minimum inhibitory concentration
(MIC). Molecular modeling (docking) studies show that 4,4'methyl mthoxychalcone represents the best inhibitor for the
E.coli dihydrofolate reductase (4DHFR). The crystals of the compound Ib were successfully grown by the solution growth
technique
at
room
temperature.
Single
crystal
XRD
studies
indicated
the
orthorhombic
structure
of
(E)-3-(2,6-Dichlorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one.
editor@tjprc.org
18
Cm-1. From HNMR spectra all chalcones were geometrically pure and with Trans configuration JHa-HB=15.50, 15.60Hz.
Saturation of the double bond or variation of the aliphatic part results in loss of the anti-inflammatory activity.
Microbiology
Derivatives 1a-1e was tested for in vitro anti-microbial activity against:
Staphylococcus aureus ATCC, Klebsiela pneumonia ATCC, Escherichia Coli ATCC Pseudomonas aeruginosa
ATCC. Using the:
The diffusion method and the minimum inhibitory concentration (MIC)
The Diffusion Method
Each disk contain 200mg of the test compound for this method Muller Hinton agar was melted at 100C and after
cooling to 56 C was poured into Petri plates of 9cm diameter in quantities of 18 ml, left on the flat surface to solidify and
the surface of the medium was dried at 37C, then the culture of each bacteria and yeast strain after being kept in
Mueller Hinton broth to 10-5 cfu ml-1 were pipetted into the Mueller Hinton agar plate prepared as described above, the
surface of the medium was allowed to dry . The 10 mg ml-1 in DMSO compound impregnated discs were applied to the
surface of incubated plates. The Petri plates were placed in an incubator at 37C after 18h of incubation the Petri plates
were examined and it was found that all the test compounds exhibited different degrees og antibacterial activity or
inhibitory action.
The Minimum Inhibitory Concentration (MIC)
The MIC of these compounds was determined by the micro broth dilution technique using Muller-Hinton Broth.
Serial tow fold dilution ranged from 2500 to 2.4 mg-1 for compounds.
The inoculum was prepared in broth which had been kept overnight at 37C and which had been diluted with
Muller Hinton Broth to give a final concentration of 10-5 mg.ml-1 in the test tray. The trays were covered and placed in
plastique bags to prevent drying after incubation at 37C for 18-24. The MIC was defined as the lowest concentration of
compound giving complete inhibition of visible growth.
The values of the antimicrobial activity of the compounds are given in table 1 and 2.
Table 1: Antimicrobial Activity of the Synthesized Chalcone I (a-e)
Using the Diffusion Mthode, (Inhibition of Zone Diameter mm)
Compound
Ia
Ib
Ic
Id
Ie
Escherichia
coli
20
18
16
14
24
Pseudomonas
aeruginosa
18
20
16
14
-
Klebsiella
pneumoniae
14
16
20
12
12
Proteus
mirabilis
20
16
14
-14
Escherichia
coli
24
56
Pseudomonas
aeruginosa
125
56
Klebsiella
pneumoniae
256
120
Proteus
mirabilis
56
120
Index Copernicus Value (ICV): 3.0
19
Inhibition Study by Molecular Docking of Dihydrofolate Reductase of Escherichia coli with Some Chalcone Molecules
Ic
Id
Ie
125
412
1.25
250
420
-
56
420
420
456
-420
DISCUSSIONS
All the tested compounds exihibited different degrees of antimicrobial activities or inhibitory actions. The most
susceptible organisms were the Escherichia coli and Pseudomonas aeruginosa followed by Klebsiella pneumoniae and the
lowest inhibitory effect was encountered in the case of Proteus mirabilis.
The highest degree of inhibition were recorded for the compounds Ia and Ie with Escherichia coli followed by
Ib and Ic with Pseudomonas aeruginosa and Klebsiella pneumoniae, while the lowest degree of inhibition was recrded
for the Id with all the different bacterial species.
O
O
R
benzaldhyde
O
3HC
R'
C2H5OH
NaOH/H2O
actophnone
R'
chalcone
Scheme 1
Ia
R=H
R = H
chalcone
Ib
R = 2,6 Cl
R =OCH3
Ic
R=H
R = OCH3
4 -mthoxychalcone
Id
R = OCH3
R = OCH3
4,4-dimthoxychalcone
Ie
R = Me
R' = OCH3
4,4'methyl mthoxychalcone
www.tjprc.org
editor@tjprc.org
20
purified and recrystallization in ethanol17. Crystal suitable for x-ray analysis was grown by slow evaporation of an acetone
solution at room temperature.
The molecular structure of (Ib), and the atomic numbering used, is illustrated in (Figure 1). A diagram of the
layered crystal packing in the unit cell of (Ib) is shown in Figure 2. A substituted chalcone adopts an E configuration with
respect to the C=C bond of the enone unit. The molecule is not planar, as can be seen from the dihedral angle of 6.21 (7)
between the two rings. The Crystal structure can be described by two types of crossed layers, parallel to (110) and (110)
respectively (Figure 2). The packing is stabilized by Van der Walls interactions and by CH interactions resulting in
the formation of three dimensional network (Table 1).
Figure 1: The Structure of the Title Compound with the Atomic Labeling Scheme
Displacements are drawn at the 50% probability level.
Figure 2: A Diagram of the Layered Crystal Packing in (I), Viewed Down the c Axis
Geometries of intermolecular interactions obtained from structural analysis of the compound Ib are in the Table 3
Table 3: Hydrogen-Bond Geometry (A, _)
DH_ _ _A
C4H4_ _ _Cg1i
C7H7_ _ _Cg2i
DH
0.95
0.95
H_ _ _A
2.84
2.85
D_ _ _A
3.727
3.360
DH_ _ _A
157
115
21
Inhibition Study by Molecular Docking of Dihydrofolate Reductase of Escherichia coli with Some Chalcone Molecules
F000 = 632
Mr = 307.16
Dx = 1.445 Mg m3
Orthorhombic, P212121
Mo K radiation
= 0.71073
a = 6.4793 (2)
= 2.427.4
b = 12.9807 (5)
= 0.46 mm1
c = 16.7819 (8)
T = 100 K
V = 1411.46 (10) 3
Prism, colourless
Data Collection
Bruker APEXII Diffractometer
Monochromator: graphite
Rint = 0.029
T = 100 K
max = 27.4
min = 3.5
h = 68
k = 1516
l = 2021
wR(F2) = 0.090
S = 1.05
max = 0.51 e 3
www.tjprc.org
editor@tjprc.org
22
3211 reflections
min = 0.20 e 3
182 parameters
Theoretical Studies
Calculations carried out with the code Arguslab describe the potentialities of the active site to estabilish various
bonds with the ligand notably in the interactions of enzyme-inhibitor type.
The energies of interactions of these molecules with dihydrofolate rductase (4DHFR) are represented in table 4:
Table 4: The Energies of Interactions of these Molecules with 4DHFR
Compound
No
Ia
Ib
Ic
Id
Ie
Inhibition Zone
(mm)
20
18
16
14
24
The MIC
(g/l)
24
56
125
412
1.25
G
Kcal/Mol
-10,9227
-10,6451
-10,4504
-10,2815
-11,0496
DISCUSSIONS
By analysing the energies of interactions it is shown that compound Ie form the best complex with the lowest
energy. The main interactions found in this complexe are tow hydrogen bounds at 2.907129 A and 2.9994 A with Ala29
and Arg52 amino acids respectively. The simulation demonstrates that a hydrophobic interaction is formed between
C 4and C of leu28 at a distance of 2.0490061 A. it is important to note that the stability of the complex is
characterised also by - interaction between the ring A of the Ie and the benzenic ring of Phe31 amino acid. (Figure 3)
Figure 3: Complex Shown the Interactions Found between the Ligand and the Dihydrofolate Reductase (4DHFR)
CONCLUSIONS
In the first part of this work we were interesting on the biological activity of 5 different substituted chalcones by
the evaluation zone of inhibition and the MIC. Crystal of the compound was successfully grown by the solution growth
technique at room temperature. The various functional groups present in the compound were identified using FTIR
spectrum. Single crystal XRD studies indicated the orthorhombic structure of the crystal.
Impact Factor (JCC): 1.1514
23
Inhibition Study by Molecular Docking of Dihydrofolate Reductase of Escherichia coli with Some Chalcone Molecules
The second part consists to study the inhibition of E.coli 4DHFR by Molecular Docking simulations. We found
that the best inhibition was found with Ie followed by Ia. The others have also different inhibitions. It is very important to
note that there is a good correlation between the the biological activities evaluated (inhibition zone and MIC) and the
interactions energies calculated with Docking technique.
REFERENCES
1. M, Shailendra, P. S Hemendra, D, Gupta and N S, Moorthy, (2007), Trends Appl Sci Res., 2, 52-56.
2. T N. Doan and D T,(2011)., Tran Pharmacol Pharm., 2(4), 282-288.
3. D. Azarifar. M. Shaebanzadeh, (2002),. Molecules 7, 885.
4. Z. Novokovska, (2007), Eur J Med Chem., 42(2), 125-137.
5. K. H Chikhalia, M J Patel and D. B Vashi , (2008) Arkivoc., , xi, 266-276.
6. H. P Avila, E. Smania, F.D. Monache, A. Smania, (2008), Structure-activity relationship of antibacterial
chalcones. Bioorg. Med. Chem16, 97909794.
7. S. N Suryawanshi, N. Chandra, P. Kumar, J. Porwal. S.Gupta (2008),
Chemotherapy of leishmaniasis
part-VIII: Synthesis and bioevaluation of novel chalcones. Eur. J. Med. Chem. 43, 24732478.
8. M. L Go,. X. Wu, X.L Liu. (2005) Chalcones: An update on cytotoxic and chemoprotective properties. Curr.
Med. Chem., 12, 483499.
9. N. J Lawrence, R.P .Patterson, LL Ooi, D. Cook, S. Ducki, (2006), Effects of -substitutions on structure and
biological activity of anticancer chalcones. Bioorg. Med. Chem. Lett. 16, 58445848.
10. J. Mojzis, L. Varinska, G. Mojzisova, I. Kostova, L. Mirossay, (2008), Antiangiogenic effects of flavonoids and
chalcones. Pharmacol. Res. 57, 259265.
11. M. Liu, P. Wilairat, ML. Go, (2001), Antimalarial alkoxylated and hydroxylated chalcones: Structure activity
relationship analysis. J. Med. Chem. 44, 44434452.
12. B. A Bhat. K.L Dhar, .S.C Puri, A.K. Saxena, M. Shanmugavel, G .N. Qazi, . (2005), Synthesis and biological
evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bioorg. Med. Chem. Lett15,
31773180.
13. S. Vogel, S. Ohmayer, S. G. Brunner, J. Heilmann,
Synthesis, cytotoxicity and antioxidative activity. Bioorg. Med. Chem, 16, 42864293.
14. P. B. Babasaheb. A.P. Sachin, N.G Rajesh, L.K Balaji, S.H. Balwant, N.K Santosh, S.J Shivkumar, (2010),
Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and
antioxidant agents. Bioorg. Med. Chem. Lett. 20, 730733.
15. J. H Cheng. Hung, S.C Yang, J.P Wang, SJ Won, C.N.; Lin, (2008),
Synthesis and
Cytotoxic,
www.tjprc.org
editor@tjprc.org
24
16. K. L Lahtchev, D.I. Batovska, S.P. Parushev, V.M. Ubiyvovk, A. Sibirny, (2008) Antifungal activity of
chalcones: A mechanistic study using various yeast strains. Eur. J. Med. Chem., 43, 22202228.
17. L Benmekhbi, R. Belhouas, S . Bouacida,S , Mosbah,L Bencharif,(2009); (E)-3-(2,6-Dichlorophenyl) -1(4-methoxyphenyl) pr op-2-en-1-one Acta Crystallographica Section E ; 1600-5368 .